Big Data: The Key to Unlocking Immune Mediated Mechanisms of Tumor Progression and Therapy Response

 Sunday, May 8, 2022     8:00 AM – 10:00 AM ET     Room B113–116

Big Data: The Key to Unlocking Immune Mediated Mechanisms of Tumor Progression and Therapy Response

Chairs

• Mary Philip, Vanderbilt Univ. Med. Ctr.
• Sepideh Dolatshahi, Univ. of Virginia

Speakers

• Joshua Brand, Univ. of Wisconsin-Madison, Single-cell myeloid diversity in human fallopian tube and its implications for early high grade serous ovarian cancer
• Nicola S. Meagher, Univ. of New South Wales, Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia
• Mieszko Lachota, Med. Univ. of Warsaw, Analysis of chemokine network in primary human glioblastoma
• Cristina F. Contreras, NCI, NIH, Transcriptomic and epigenetic profiling of tumor-associated monocyte function
• Huy Dinh, Univ. of Wisconsin-Madison, Defining myeloid plasticity and heterogeneity in immunotherapy response
• Vivien Ileana Maltez, NIAID, NIH, Multiplex microscopy reveals unique spatiotemporal effects of cancer immunotherapies
• William L. Redmond, Earle A. Chiles Res. Inst., Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy
• Abigail L. Sedlacek, Univ. of Pittsburgh, Identification of immunogenic peptide neoantigens expressed in sarcomas and their therapeutic potential